Hypoglycemic Agents: all 3,927 studies that test it

Page 19 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.

• Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting GlucoseStatus unknownNCT04662866Phase 2
• AT278 and NovoRapid® in Glucose Clamp StudyCompletedNCT04660305Phase 1
• Counteracting Deleterious Metabolic Glucocorticoid Effects With MetforminCompletedNCT04659915Phase 4
• Insulin Resistance Following ADT for Prostate CAWithdrawnNCT04658849Early Phase 1
• Targeting Beta-cell Failure in Lean Patients With Type 2 DiabetesCompletedNCT04657939Phase 4
• DPP4 Inhibitor on Glycemic VariabilityCompletedNCT04654676Phase 4
• Metformin for the Treatment of Hidradenitis Suppurativa (HS)CompletedNCT04649502Phase 3
• Post Operative Delirium StudyWithdrawnNCT04635774Phase 1/2
• Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin HydrochlorideCompletedNCT04621669Phase 1
• Fast-Acting Insulin Aspart and Insulin Pump SettingsStatus unknownNCT04620967Phase 4
• A Pragmatic Approach to Lowering the Risk of Diabetes Mellitus After A Diagnosis of Gestational Diabetes MellitusStatus unknownNCT04615351Phase 3
• Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint ArthroplastyWithdrawnNCT04613024Early Phase 1
• Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial HyperplasiaTerminatedNCT04607252Phase 2/3
• Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusTerminatedNCT04606576Phase 3
• Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19WithdrawnNCT04604678Phase 2
• Effect of Pioglitazone on T2DM Patients With COVID-19Status unknownNCT04604223Phase 4
• A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver DiseaseCompletedNCT04597697Phase 1
• Impact of Metformin on Peripheral Arterial Calcification in Type 1 DiabetesActive, not recruitingNCT04583462Phase 3
• A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 DiabetesCompletedNCT04582448Phase 1
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 DiabetesCompletedNCT04582435Phase 1
• Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial CancerActive, not recruitingNCT04576104Phase 2
• Medications After Adolescent Bariatric SurgeryWithdrawnNCT04572217Phase 2
• The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic PatientsWithdrawnNCT04569214Phase 2
• The Effect of Metformin on Breast Cancer PatientsStatus unknownNCT04559308Phase 2
• Intensive Insulin Therapy as Therapeutic Strategy for Non-diabetic Hyperglycemia After Surgery in ICUCompletedNCT04554615Not applicable
• The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With PrediabetesCompletedNCT04549415Phase 4
• Oral Metformin for Treatment of ABCA4 RetinopathyActive, not recruitingNCT04545736Phase 1/2
• Combination GRA and SGLT-2i Treatment in Type 1 DiabetesCompletedNCT04545411Phase 1/2
• Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19CompletedNCT04542213Phase 3
• Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational DiabetesActive, not recruitingNCT04542148Phase 2
• Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19CompletedNCT04535700Phase 4
• A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GISTCompletedNCT04530981Phase 1
• Fenofibrate Versus Curcumin in Type 2 Diabetic PatientsCompletedNCT04528212Phase 4
• Metformin Versus Standard of Care Treatment in Pregnant Women With PrediabetesWithdrawnNCT04523363Phase 4
• Metformin's Effect on Drug Metabolism in Patients With Type 2 DiabetesTerminatedNCT04504045Phase 1
• Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp MethodCompletedNCT04501250Not applicable
• Effect of Metformin on Non PCO Women Undergoing IVF/ICSICompletedNCT04489147Not applicable
• Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications ProgressionStatus unknownNCT04485845Phase 4
• Suloexide in the Treatment of Early Stages of COVID-19CompletedNCT04483830Phase 2/3
• GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot StudyCompletedNCT04473274Phase 4
• Glimepiride, Alogliptin and Alogliptin+Pioglitazone CombinationStatus unknownNCT04470310Phase 4
• A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor SubjectsCompletedNCT04457180Phase 1
• Treatment of Obesity With Topiramate in Patients With Polycystic Ovary SyndromeStatus unknownNCT04453306Phase 4
• A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of MeforminCompletedNCT04448821Phase 1
• Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host DiseaseStatus unknownNCT04448587Phase 2
• A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.CompletedNCT04428086Phase 1
• Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 DiabetesCompletedNCT04426422Phase 4
• The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction BolusStatus unknownNCT04414579Phase 4
• The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder PatientsWithdrawnNCT04410341Phase 1/2
• Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist StudyCompletedNCT04409795Phase 2/3
• Basal Insulin Glycemic ControL With DEglugec vs Aspart Via PumpCompletedNCT04409587Phase 4
• The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male SubjectsCompletedNCT04401137Phase 1
• Anti-inflammatory Status in DM2 Treated PatientsStatus unknownNCT04392557Phase 4
• Effect of Insulin on Wound Healing-A Randomized Controlled TrialStatus unknownNCT04390815Phase 4
• Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 DiabetesStatus unknownNCT04390295Phase 3
• Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.Status unknownNCT04387630Phase 2/3
• Metformin in Dengue With ObesityCompletedNCT04377451Phase 1/2
• Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19TerminatedNCT04371978Phase 3
• The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic PatientsStatus unknownNCT04365517Phase 3
• Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)CompletedNCT04349696Phase 4
• Effects of DPP4 Inhibition on COVID-19WithdrawnNCT04341935Phase 4
• Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.Active, not recruitingNCT04341571Phase 2
• Metformin to Treat Corticosteroids-induced HyperglycemiaCompletedNCT04332393Phase 4
• Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)TerminatedNCT04330625Phase 1
• Intensive Glycemic Control For Diabetic Foot Ulcer HealingStatus unknownNCT04323462Phase 4
• Effects of Sitagliptin in Individuals With Genetically Decreased DPP4Active, not recruitingNCT04323189Phase 4
• Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.CompletedNCT04317703Phase 1
• Effects of Local Insulin on Varicose Ulcers for Wound HealingCompletedNCT04310280Phase 3
• Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)CompletedNCT04304261Phase 3
• Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 DiabetesStatus unknownNCT04298684Phase 4
• Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownNCT04287387Phase 4
• Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac SurgeryStatus unknownNCT04284722Phase 4
• Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACCCompletedNCT04275713Phase 2
• Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS PatientsStatus unknownNCT04268563Phase 1/2
• A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677CompletedNCT04268394Phase 1
• Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral InfectionCompletedNCT04267809Phase 2
• A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to CopanlisibTerminatedNCT04253223Phase 1
• Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot StudyWithdrawnNCT04252612Early Phase 1
• Calorie Restriction With or Without Metformin in Triple Negative Breast CancerStatus unknownNCT04248998Phase 2
• Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 DiabetesStatus unknownNCT04243629Not applicable
• Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During RamadanCompletedNCT04237493Phase 4
• The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy VolunteersCompletedNCT04231617Not applicable
• Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substrates Digoxin, Rosuvastatin, and MetforminCompletedNCT04231435Phase 1
• Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus PatientsStatus unknownNCT04226105Phase 3
• MeDiGes Study: Metformine Use in Gestational DiabetesStatus unknownNCT04222348Phase 3
• Comparison of Myoinositol and Metformin in PCOStatus unknownNCT04204044Early Phase 1
• Methotrexate and Metformin in Rheumatoid Arthritis PatientsCompletedNCT04196868Phase 2
• Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)CompletedNCT04196231Phase 4
• A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy SubjectsCompletedNCT04184492Not applicable
• A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy SubjectsCompletedNCT04184466Not applicable
• Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis BCompletedNCT04182321Not applicable
• Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin TreatmentStatus unknownNCT04177303Phase 3
• The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLCTerminatedNCT04170959Phase 2
• Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO)CompletedNCT04170465Phase 2
• Added Value of N Acetyle Cysteine to Clomiphene Citrate in PCOCompletedNCT04170439Not applicable
• Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting ConditionStatus unknownNCT04161404Phase 1
• A Study of LY3556050 in Healthy ParticipantsCompletedNCT04156750Phase 1
• Effect of Metformin on Visual Function in Patients With GlaucomaStatus unknownNCT04155164Not applicable
• Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine TreatmentStatus unknownNCT04154813Not applicable
• Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome PatientsStatus unknownNCT04151459Not applicable

← Hypoglycemic Agents overview